The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's disease.
Jonny Daborg; Ulf Andreasson; Marcela Pekna; Ronald Lautner; Eric Hanse; Lennart Minthon; Kaj Blennow; Oskar Hansson; Henrik Zetterberg (Profiled Author: Blennow, Kaj)
Department of Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, 405 30, Gothenburg, Sweden. firstname.lastname@example.org
Journal of neural transmission (Vienna, Austria : 1996) 2012;119(7):789-97.
Alzheimer's disease (AD) is strongly associated with loss of synapses. The complement system has been shown to be involved in synaptic elimination. Several studies point to an association between AD and the complement system. The purpose of this study was to examine the association of cerebrospinal fluid (CSF) levels of complement components 3 and 4 (C3 and C4, respectively), and complement receptor 1 (CR1) with AD in 43 patients with AD plus dementia, 42 patients with mild cognitive impairment (MCI) who progressed to AD during follow-up (MCI-AD), 42 patients with stable MCI and 44 controls. Complement levels were also applied in a multivariate model to determine if they provided any added value to the core AD biomarkers Aβ42, T-tau and P-tau. We found elevated CSF levels of C3 and C4 in AD compared with MCI without progression to AD, and elevated CSF levels of CR1 in MCI-AD and AD when these groups were merged. These results provide support for aberrant complement regulation as a part in the AD process, but the changes are not diagnostically useful.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Brit-Maren M Schjeide; Cathrin Schnack; Jean-Charles Lambert; Christina M Lill; Julia Kirchheiner; Hayrettin Tumani; Markus Otto; Rudolph E Tanzi; Hans Lehrach; Philippe Amouyel; et al.Archives of general psychiatry 2011;68(2):207-13.
N Brouwers; C Van Cauwenberghe; S Engelborghs; J-C Lambert; K Bettens; N Le Bastard; F Pasquier; A Gil Montoya; K Peeters; M Mattheijssens; et al.Molecular psychiatry 2012;17(2):223-33.
Elin S Blom; Vilmantas Giedraitis; Henrik Zetterberg; Hiroaki Fukumoto; Kaj Blennow; Bradley T Hyman; Michael C Irizarry; Lars-Olof Wahlund; Lars Lannfelt; Martin IngelssonDementia and geriatric cognitive disorders 2009;27(5):458-64.
Appears in this Publication
Author of this Publication